This article is in the news archive.
£17 million awards add to momentum of UK neurodegenerative disease research
Three new research programmes focusing on devastating neurodegenerative diseases – Alzheimer's disease, Parkinson's disease and motor neurone disease – have received £17 million from the Wellcome Trust and the Medical Research Council (MRC).
The multi-disciplinary collaborations aim to provide a better understanding of the causes of these diseases in a bid to improve early diagnosis and develop more effective therapies.
The motor neurone disease and frontotemporal dementia research programme is led by Professor Christopher Shaw, MRC Centre for Neurodegeneration Research, King’s College London. This programme will focus on investigating RNA-processing proteins deposited in degenerating nerve cells and that rare mutations in three known genes cause a genetic form of these diseases.
For further information about these new research programmes focusing on devastating neurodegenerative diseases please follow the links to the Wellcome Trust and the Medical Research Council news pages.
Announced on the 2nd November, 2009.
Posted on 03/11/2009
Go to the news index page.